Skip to content
Pharma Observatory a Scientist.com platform

Clinical trial

Can Pharmacogenomic Testing Improve Response and Avoid Adverse Effects With Clopidogrel Therapy? A Biospecimen Bank for Genetic and Genomic Investigation of Clopidogrel.

NCT01611545 is registered in ClinicalTrials.gov with Avera McKennan Hospital & University Health Center as lead sponsor.

NCT NCT01611545
Email me this page as a PDF

Search trials, sites, companies and investigators, and follow each one to the others. Individual plan, $249/seat/mo. Card required.

Get the NCT01611545 report as a PDF

The PDF carries up to 50 rows of each section, where the page shows the first few, with the sources listed. Enter a work email and confirm it from the message we send, and the report follows by email.

Registry record

As filed in ClinicalTrials.gov.

Title
Can Pharmacogenomic Testing Improve Response and Avoid Adverse Effects With Clopidogrel Therapy? A Biospecimen Bank for Genetic and Genomic Investigation of Clopidogrel.
Lead sponsor
Avera McKennan Hospital & University Health Center
Phase
Observational
Overall status
Completed
Start date
June 30, 2012
Completion date
January 31, 2015
Enrollment
130 (actual)
Sites
1

Conditions

As the registry lists them; a condition with its own page is linked.

pharmacogenomics and cardiovascular events